History

History

20th Anniversary of Jazz Pharmaceuticals founding

Jazz expands support for American Heart Association

2023
 
 
2016

Opened new manufacturing facility in Athlone, Ireland and received a Facility of the Year Award in 2017 from the International Society for Pharmaceutical Engineering (ISPE) for Best Project Execution

Acquired Celator Pharmaceuticals, which added Vyxeos®

U.S. launch of Defitelio®

 
2010

Defibrotide was available in Australia under the Special Access Scheme (SAS).

Acquired Orphan Medical and its product, Xyrem®

2005
 
 
2004

Management team assembled/capital raised

Jazz Pharmaceuticals founded

2003
 
Jazz Pharma AU Quotes
 

When I co-founded Jazz Pharmaceuticals, our vision was to create a company with a constant focus on patients and a commitment to being a great place to work.”

Bruce Cozadd, Chairman and CEO